Nemluvio Galderma Australia Pty Ltd
Product name
Nemluvio
Sponsor
Accepted date
May-2024
Active ingredients
nemolizumab
Proposed indication
For the treatment of moderate-to-severe atopic dermatitis.
Application type
A (new medicine)
Publication date
May-2024